Tamidety is the co-founder and CEO of [SV Health Investors portfolio company] Nanopath, which aims to make next-generation diagnostics with a faster turnaround time than traditional tests.
View the article
in Portfolio News
Tamidety is the co-founder and CEO of [SV Health Investors portfolio company] Nanopath, which aims to make next-generation diagnostics with a faster turnaround time than traditional tests.
We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.